Alpharma Bio

Alpharma, established in 2013 in Nanjing, China, is a biopharmaceutical company focusing on developing and commercialization of human cardiomyocytes derived from pluripotent stem cells. We have a two pronged business models: 1. We provide human cardiomyocytes as research supplies in cardiotoxicity analysis of drug development. 2. We are developing cell transplantation therapy for Myocardial Infarction (MI, heart attack)